Skip to Content

Tag: diabetes


Specialty Providers

Medtronic aims to ‘bridge’ coverage gaps 

December 18, 2020Theresa Flaherty, Managing Editor

DUBLIN – The biggest barrier to CGMs and other innovative diabetes technology is cost, says Medtronic, and that’s why the company recently launched a CGM Access Discount Program for certain users.  “Our goal is to make therapy available to everyone and we hear cost is one of the top reasons they can’t go on CGMs or fall off (using CGMs),” says Krista Sugerman, vice president of global customer engagement for Medtronic. “We try to...

CGMs, CMS, diabetes, Medtronic


Read Full Articlered right arrow icon

Pinnacle Medical Solutions gets ‘bigger seat at table’ 

Specialty Providers

Pinnacle Medical Solutions gets ‘bigger seat at table’ 

December 18, 2020Theresa Flaherty, Managing Editor

CHICAGO - With the diabetes management industry growing by leaps and bounds, Frank Brumfield, CEO and owner of FSB Companies, a private investment firm, knew it was time to sell Pinnacle Medical Solutions, a company he’s been involved with since 2006.  “We’re excited to plug in the patient-focus model that The FSB Companies and the Pinnacle management team had built over the years into a much broader platform,” he said. “We wanted to be able to continue...

AdaptHealth, CGMs, diabetes, Frank Brumfield, Pinnacle Medical Solutions


Read Full Articlered right arrow icon

Also Noted

Medtronic launches discount program

December 3, 2020HME News Staff

DUBLIN - Medtronic has launched a CGM Access Discount program that allows users without insurance coverage or those who switched insurance or lost coverage to access discounted out-of-pocket costs for a Medtronic CGM. The discount enables eligible patients to pay $180 for a Medtronic CGM (with a 12-month warranty) and $60/month for sensors. For more information on the program, click here. In October, CMS announced proposed changes that, if finalized, would expand Medicare coverage for CGMs. Earlier...

CGMs, diabetes, Medtronic


Read Full Articlered right arrow icon

Also Noted

DarioHealth sees 3Q revenues increase

November 12, 2020HME News Staff

NEW YORK - DarioHealth reported revenues of $2.04 million for the quarter ended Sept. 30, 2020, an increase of 14.2% from the second quarter ended June 30, 2020. Gross profit was $549,000, a decrease of $324,000 or 37% from the previous quarter in 2019. The company said the decrease is a result of a decrease in the average selling price of its products. Total operating expenses for the quarter were $7.15 million, operating loss was $6.6 million, and net loss was $6.55 million. Highlights from the...

DarioHealth, diabetes


Read Full Articlered right arrow icon

Providers

AdaptHealth seeks to 'unlock' diabetes market

November 6, 2020Theresa Flaherty, Managing Editor

PLYMOUTH MEETING, Pa. - The diabetes market is a “high priority” for AdaptHealth as it seeks both strategic and organic growth, say company officials. The company, which closed on Solara Medical Supplies in July, acquired several additional supply and home medical businesses in the third quarter, most recently Pinnacle Medical Solutions, a provider of diabetes supplies, including continuous glucose monitors and insulin pumps, on Oct. 1. “We like the landscape in diabetes,”...

AdaptHealth, CGMs, diabetes


Read Full Articlered right arrow icon

Also Noted

Insulet aims to increase diabetes awareness

November 5, 2020HME News Staff

ACTON, Mass. - Insulet Corp. has launched “YESvember,” a monthlong campaign to share inspiring stories of people living with diabetes on social media channels. The company is encouraging people to share how they are turning “no, I can't” into “yes, I can.” “We understand the many obstacles faced by people with diabetes and those who care for them,” said Shacey Petrovic, president and CEO. “Our innovative technology makes it possible for people...

diabetes, insulet, YESvember


Read Full Articlered right arrow icon

Also Noted

LifeScan, Truepill partner on e-commerce channel for OneTouch Reveal users

October 27, 2020HME News Staff

MALVERN, Pa. - LifeScan has partnered with Truepill, a digital health platform providing consumer health experiences through its API-connected infrastructure. Through the partnership, LifeScan will leverage Truepill's platform to provide OneTouch brand diabetes self-management supplies, including test strips, lancing devices and blood glucose monitors, directly to the homes of patients. “LifeScan's OneTouch Reveal app is already providing meaningful resources, helping users understand patterns...

diabetes, digital health, e-commerce, LifeScan, Truepill


Read Full Articlered right arrow icon

Specialty Providers

Ascensia bets on CGMs

September 4, 2020Theresa Flaherty, Managing Editor

BASEL, Switzerland - Ascensia's new partnership with Senseonics is a big nod to continuous glucose monitors as the next best step in diabetes management. In August, Ascensia partnered with Senseonics to distribute its implantable CGM systems, including the Eversense and Eversense XL and future generation products, broadening its product portfolio beyond blood glucose monitoring systems, including its popular Contour line. “We certainly have a vision to be able to grow in the BGM space, (but)...

Ascensia, CGMs, diabetes, Senseonics


Read Full Articlered right arrow icon

Also Noted

Medtronic makes 'strategic' acquisition in diabetes market

August 12, 2020HME News Staff

DUBLIN and SAN DIEGO - Medtronic plans to acquire Companion Medical, the manufacturer of InPen, a smart insulin pen system paired with an integrated diabetes management app. The InPen, which has been cleared by the U.S. Food and Drug Administration, expands Medtronic's ability to serve people where they are in their diabetes journey and offer them a unique and expansive ecosystem of support, the company says. “This acquisition is an ideal strategic fit for Medtronic, as we further simplify...

diabetes, M&A, Medtronic


Read Full Articlered right arrow icon

Also Noted

Ascensia partners with Senseonics on implantable CGMs

August 11, 2020HME News Staff

BASEL, Switzerland - PHC Holdings Corporation and Ascensia Diabetes Care have announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. As part of the agreement, Ascensia will serve as the exclusive global distribution partner for Senseonics' CGM systems, including Eversense, Eversense XL and future generation products...

Ascensia Diabetes Care, CGMs, diabetes, Eversense, Senseonics


Read Full Articlered right arrow icon